Furthermore, in a large population-based study carried out in Denmark, statin use was associated with a reduced risk of breast cancer recurrence in postmenopausal women receiving adjuvant aromatase inhibitors (following multivariate analysis, HR 0.72; 95% CI 0.50–1.04) [36]. The gene discussed is CYP19A1; the disease is breast carcinoma.